Monitoring and preventing delirium in patients using advanced technology
ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
This study is testing a new system called ADAPT that helps keep track of how well patients move and sleep in real-time, especially in intensive care, to predict and prevent confusion (delirium) by making their environment better and helping them stay active.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11091453 on NIH RePORTER |
What this research studies
This research focuses on developing a system called ADAPT, which uses advanced sensing and deep learning techniques to monitor patients' mobility and circadian rhythms in real-time. By quantifying factors such as nightly disruptions, light intensity, and noise levels, the system aims to predict the likelihood of delirium in patients, particularly in intensive care settings. The goal is to provide timely interventions that can enhance patient mobility and optimize their environment, ultimately improving their overall care and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients, particularly those in intensive care units who are at risk for delirium due to advanced illness or acute conditions.
Not a fit: Patients who are not hospitalized or those who do not exhibit risk factors for delirium may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention of delirium in hospitalized patients, improving their recovery and quality of life.
How similar studies have performed: Other research has shown promise in using technology for monitoring patient conditions, suggesting that this approach could be effective in preventing delirium.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Rashidi, Parisa — University of Florida
- Study coordinator: Rashidi, Parisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.